English | Español

Regulatory
+ Regulatory
Patient Daily Report | May 18, 2023

NYU Langone Health professor: 'This study is the first collaboration of this focus and scale to find that adults with sleep apnea are at greater risk for long COVID'
+ Regulatory
Patient Daily Report | May 15, 2023

Perrigo VP: 'Today's vote reflects the strong data showing that Opill® can be used safely and effectively over the counter'
+ Regulatory
Patient Daily | May 9, 2023

Lilly Declares Second-Quarter 2023 Dividend
+ Regulatory
Patient Daily Report | May 8, 2023

FDA approves first RSV vaccine for use in United States: 'Today's approval of the first RSV vaccine is an important public health achievement'
+ Regulatory
Patient Daily | May 7, 2023

Tandem Diabetes Care Announces First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Guidance
+ Regulatory
Patient Daily | May 7, 2023

Horizon Therapeutics plc Reports First-Quarter 2023 Financial Results
+ Regulatory
Patient Daily | May 7, 2023

Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
+ Regulatory
Patient Daily | May 7, 2023

Integra LifeSciences Reports First Quarter 2023 Financial Results

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes